| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |